Med Page Today
JUNE 23, 2024
(MedPage Today) -- ORLANDO -- For type 1 diabetes patients, switching from an insulin pump or multiple daily injections to inhaled insulin (Afrezza) maintained glycemic control -- for those who used it as intended, the INHALE 3 trial showed.
DAIC
FEBRUARY 14, 2025
Led by Mehdi Shishehbor DO, MPH, PhD, interventional cardiologist and a pioneer in the field of limb preservation, the Dodero Center will revolutionize care for patients at risk of losing a leg due to peripheral artery disease and diabetes. For patients with no other options, amputation may become imminent.
DAIC
MAY 14, 2024
UVA Health's Karen Johnston, MD, the SHINE trial leader, was pleased to see the new insights into best practices for stroke care. Approximately 80% had type 2 diabetes. Johnston, the SHINE trial leader, was pleased to see the new insights into best practices for stroke care.
DAIC
FEBRUARY 14, 2025
Led by Mehdi Shishehbor DO, MPH, PhD, interventional cardiologist and a pioneer in the field of limb preservation, the Dodero Center will revolutionize care for patients at risk of losing a leg due to peripheral artery disease and diabetes. For patients with no other options, amputation may become imminent.
Stroke Journal
JANUARY 30, 2025
vs 7.9%), diabetes (33.6% While there was no change in mortality in the thrombectomy plus stent group over time, there was a significant trend towards better outcomes with lower mortality in the stenting only cohort, suggesting improved outcomes with best practice techniques and better patient selection criteria for endovascular therapy
DAIC
FEBRUARY 1, 2024
We could not show it in a short study like this, but I believe this approach of integrating genetic information into routine best practices could save lives and be a game-changer for patients and GPs. I am proud to have led such a ground-breaking study."
Expert insights. Personalized for you.
92 
Let's personalize your content